Financial Data and Key Metrics Changes - Sales for Q3 2023 were 323million,adecreaseofapproximately337 million, with a loss of adjusted earnings per share of 0.36[11][12]−Freecashflowwasnegative4 million, with cash flow from operations decreasing by roughly 38millionyear−over−year[12]BusinessLineDataandKeyMetricsChanges−TheNylonSolutionssegmentcontinuedtoexperiencedeclines,withglobalcompositecaprolactam−over−benzenespreadsdownnearly204.5 million pre-tax income impact from three one-time transactions, which were excluded from adjusted EBITDA results [11] - Capital expenditures for the full year 2023 are expected to be approximately $115 million, reflecting increased spending on critical infrastructure and growth projects [30] Q&A Session Summary Question: Details on the exit from the partnership with Oben - Management clarified that the exit involves transitioning sales and distribution aspects to Oben while maintaining resin supply, allowing focus on core capabilities [34][36] Question: Impact of the nylon downturn on product mix - Management indicated that efforts are being made to commercialize recycled content products to maintain a favorable product mix during the downturn [38][40] Question: Resilience of the Chemical Intermediates portfolio - Management noted that while pricing and margins are resilient, demand has declined due to destocking, particularly in the Ag chemical space [51] Question: Order book for ammonium sulfate - Management confirmed a robust order book consistent with historical levels, expecting continued strength as they approach the spring application season [49] Question: M&A opportunities in the current environment - Management expressed openness to evaluating accretive M&A opportunities that align with their disciplined capital allocation approach [67][68]